American National Bank Chroma Dex Corp. Transaction History
American National Bank
- $860 Million
- Q4 2024
A detailed history of American National Bank transactions in Chroma Dex Corp. stock. As of the latest transaction made, American National Bank holds 2,446 shares of CDXC stock, worth $14,382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,446Holding current value
$14,382% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
97Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$20.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$18.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$17.4 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.62 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.76 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $402M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...